Carisma Therapeutics Inc [CARM] Revenue clocked in at $10.77 million, down -81.30% YTD: What’s Next?
Carisma Therapeutics Inc [NASDAQ: CARM] stock went on a downward path that fall over -5.70% on Monday, amounting to a one-week price decrease of less than -8.90%. Over the last 12 months, CARM stock dropped by -48.66%. The one-year Carisma Therapeutics Inc stock forecast points